semaglutide prediabetes progression to diabetes step trial 2.4 mg weekly vs 1 mg and placebo in #obesity with T2 #diabetes Better weight loss, better reduction in waist circumference and slightly better HbA1c lowering (sugars) with fewer other sugar-lowering Semaglutide 2·4 mg once a

At the Arena Dairy Innovation Strategies conference, experts discussed how these drugs change consumer perceptions of protein and sweetness

Diabetes/Metabolism Research and Reviews, 26 (5), 323-335

Currently, five states offer unrestricted Medicaid coverage for Wegovy, and four states offer restricted coverage with prior authorization

Hypertension and dyslipidemia were the most common obesityrelated comorbidities among the patient cohort (44% and 42%, respectively)

Additionally, while semaglutide reduced N-terminal pro-B-type natriuretic peptide (NT-proBNP) across all categories of weight loss achieved, patients experiencing the greatest weight loss exhibited the smallest reduction in NT-proBNP 44